Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial.
| Autor: | Cassidy, J.1 j.cassidy@beatson.gla.ac.uk, Douillard, J.-Y.2, Twelves, C.3, McKendrick, J. J.4, Scheithauer, W.5, Bustová, I.6, Johnston, P. G.7, Lesniewski-Kmak, K.8, Jelic, S.9, Fountzilas, G.10, Coxon, F.11, Díaz-Rubio, E.12, Maughan, T. S.13, Malzyner, A.14, Bertetto, O.15, Beham, A.16, Figer, A.17, Dufour, P.18, Patel, K. K.19, Cowell, W.20 |
|---|---|
| Zdroj: | British Journal of Cancer. 4/24/2006, Vol. 94 Issue 8, p1122-1129. 8p. 5 Charts, 3 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|